Coloplast A/S (CLPBY) Earnings Date, Estimates & Call Transcripts $13.99 +0.25 (+1.82%) (As of 09/13/2024 08:54 PM ET) Add Compare Share Share EarningsStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest Earnings SummaryLatest Earnings DateAug. 20EstimatedActual EPS (Aug. 20) $0.08 Beat By $0.08 Get Coloplast A/S Earnings AlertsEnter your email address below to receive the latest news and earnings results for CLPBY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCLPBY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLPBY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Brownstone ResearchBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate Coloplast A/S Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$0.34 EPSNext Year EPS Consensus Estimate: $0.40 EPSCLPBY Earnings Date and InformationColoplast A/S last announced its quarterly earnings data on August 20th, 2024. The reported $0.08 earnings per share for the quarter. The business had revenue of $993.49 million for the quarter. Coloplast A/S has generated $0.33 earnings per share over the last year ($0.33 diluted earnings per share) and currently has a price-to-earnings ratio of 42.4. Earnings for Coloplast A/S are expected to grow by 17.65% in the coming year, from $0.34 to $0.40 per share. Read More Coloplast A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/20/2024Q3 2024-$0.08+$0.08$0.08-$993.49 million5/7/2024Q2 2024$0.08$0.08-$0.08-$959.05 million2/9/2024Q4 2023$0.08$0.08-$0.08-$953.60 million11/9/2023Q4 2023-$0.08+$0.08$0.08-$909.23 million8/17/2023Q3 2023-$0.09+$0.09$0.09-$892.53 million5/11/2023Q2 2023-$0.08+$0.08$0.08-$873.63 million Get the Latest News and Ratings for CLPBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter. 2/3/2023Q1 2023-$0.07+$0.07$0.07-$838.06 million11/7/2022Q4 2022-$0.08+$0.08$0.08-$820.87 million8/17/2022Q3 2022-$0.09+$0.09$0.09-$837.70 million5/5/2022Q2 2022-$0.09+$0.09$0.11-$829.69 million1/25/2022Q1 2022-$0.09+$0.09$0.09-$794.87 million11/1/2021Q4 2021-$0.10+$0.10$0.10-$808.60 million8/18/2021Q3 2021-$0.10+$0.10$0.10-$783.31 million5/6/2021Q2 2021-$0.10+$0.10$0.11-$770.35 million2/2/2021Q1 2021-$0.09+$0.09$0.09-$759.18 million11/3/2020Q4 2020-$0.08+$0.08$0.08-$720.63 million8/18/2020Q3 2020-$0.07+$0.07$0.07-$652.28 million5/6/2020Q2 2020-$0.07+$0.07$0.07-$711.92 million11/5/2019Q4 2019-$0.08+$0.08$0.10-$687.96 million Coloplast A/S Earnings - Frequently Asked Questions When did Coloplast A/S announce their last quarterly earnings? Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earning data on Tuesday, August 20, 2024. Learn more on CLPBY's earnings history. What guidance has Coloplast A/S issued on next quarter's earnings? Coloplast A/S issued an update on its FY 2024 earnings guidance on Tuesday, August, 20th. The company issued revenue guidance of $3.9 billion-$3.9 billion. How much revenue does Coloplast A/S generate each year? Coloplast A/S (OTCMKTS:CLPBY) has a recorded annual revenue of $3.58 billion. How much profit does Coloplast A/S generate each year? Coloplast A/S (OTCMKTS:CLPBY) has a recorded net income of $685.88 million. CLPBY has generated $0.33 earnings per share over the last four quarters. What is Coloplast A/S's price-to-earnings ratio? Coloplast A/S (OTCMKTS:CLPBY) has a trailing price-to-earnings ratio of 42.40 and a forward price-to-earnings ratio of 41.15. The price/earnings-to-growth ratio is 3.57. What is Coloplast A/S's EPS forecast for next year? Coloplast A/S's earnings are expected to grow from $0.34 per share to $0.40 per share in the next year, which is a 17.65% increase. More Earnings Resources from MarketBeat Related Companies: EW Earnings Results STE Earnings Results ZBH Earnings Results ALGN Earnings Results MSA Earnings Results ENOV Earnings Results CDRE Earnings Results ESTA Earnings Results AVNS Earnings Results SMTI Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (OTCMKTS:CLPBY) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.